← All decks

Dermatology

Urticaria and Angioedema

Built from Dermatology, 5th Edition

The first 25 slides of Urticaria and Angioedema
The first 25 slides, exactly as they appear. The full deck has 134 content slides.

What’s inside

10 sections · 134 slides

  1. 01

    Overview

    • What this chapter covers

    1 slide

  2. 02

    Definitions and Epidemiology

    What counts as urticaria, how common it is, and who it affects

    • Wheals and angioedema
    • Appearance of wheals
    • Appearance of angioedema
    • Telling urticaria apart from look-alikes
    • Wheals vs angioedema at a glance
    • Two clinical starting points
    • 8-22%
    • Who gets urticaria

    8 slides

  3. 03

    Pathogenesis

    The mast cell, its triggers, and the bradykinin pathway behind angioedema without wheals

    • The mast cell: main driver of urticaria
    • What sets off degranulation
    • From trigger to wheal
    • Pathways that trigger mast cell degranulation
    • What a mast cell releases
    • Preformed and newly made mast cell mediators
    • How mediators make blood vessels leak
    • Autoantibodies that trigger mast cells
    • IgE and autoantibody binding to the FcεRI receptor
    • Circulating autoantibodies against other targets
    • White blood cells in chronic urticaria
    • Nerve signals and mast cells
    • Two broad routes to a wheal
    • Etiologies and pathomechanisms of wheals and/or angioedema
    • Mast cell-dependent urticaria: IgE and physical triggers
    • Cholinergic and vibratory urticaria mechanisms
    • Why chronic urticaria is often 'idiopathic'
    • Mast cell-independent urticaria
    • C1 inhibitor deficiency causes a different kind of swelling
    • Bradykinin build-up in C1 inhibitor deficiency
    • Bradykinin pathway in hereditary and drug-induced angioedema
    • HAE with normal C1 inhibitor activity
    • Acquired C1 inhibitor deficiency and ACE inhibitor angioedema

    23 slides

  4. 04

    Clinical Features

    Classifying urticaria, and the many patterns it can take

    • Classifying urticaria in the clinic
    • Urticaria – clinical classification and differential diagnosis
    • Defined by how long it lasts
    • Acute vs chronic: what the numbers show
    • Causes of acute urticaria
    • What acute urticaria teaches us
    • Causes of chronic urticaria
    • Spontaneous urticaria: who and how it presents
    • Typical spontaneous urticaria
    • Annular and arcuate wheals
    • Central pallor within annular wheals
    • Comorbidities linked to chronic spontaneous urticaria
    • How systemic disease can tint urticaria's colour
    • Urticaria triggered by viral infection
    • Inducible urticarias: triggered from outside
    • Classification of inducible urticarias by the eliciting stimulus
    • How inducible urticarias overlap and combine
    • Dermographism: 'skin writing'
    • Linear wheals of symptomatic dermographism
    • Rarer forms of dermographism
    • Delayed pressure urticaria
    • Deep swelling of delayed pressure urticaria
    • Vibratory angioedema
    • Heat contact urticaria
    • Cold urticaria: an overview
    • Ice cube test for cold urticaria
    • Cold urticaria subtypes
    • Cholinergic urticaria: triggered by sweating
    • Cholinergic urticaria after a hot bath
    • Exercise-induced anaphylaxis and adrenergic urticaria
    • Solar and aquagenic urticaria
    • Contact urticaria
    • Food contact hypersensitivity (oral allergy) syndrome
    • Angioedema without wheals: think differently
    • Drug-induced angioedema
    • Angiotensin receptor blockers and sacubitril-valsartan
    • Hereditary angioedema types I and II
    • HAE with normal C1 inhibitor activity

    38 slides

  5. 05

    Distinctive Syndromes

    Rare disorders that present with urticaria-like lesions but need their own diagnosis and treatment

    • Cryopyrin-associated periodic syndromes (CAPS)
    • Other hereditary periodic fever syndromes
    • Schnitzler syndrome
    • Other acquired syndromes with urticarial rash
    • Urticarial vasculitis
    • Urticarial vasculitis lesions
    • Urticarial vasculitis
    • Urticarial vasculitis (continued)
    • Urticarial vasculitis (continued)

    9 slides

  6. 06

    Pathology

    What a skin biopsy of urticaria actually shows

    • Histology of ordinary urticaria
    • Microscopic appearance of a spontaneous wheal
    • Neutrophilic urticaria and neutrophilic urticarial dermatosis
    • Neutrophilic urticarial dermatosis in lupus

    4 slides

  7. 07

    Diagnosis and Differential Diagnosis

    History, examination, and when to reach for tests

    • Conditions that mimic urticaria
    • Urticaria multiforme in children
    • The essential history and examination
    • Circling a lesion to time its duration
    • Investigating acute urticaria
    • Investigating chronic urticaria
    • Testing for autoimmune urticaria
    • Tests employed for autoimmune urticaria
    • Tests employed for autoimmune urticaria (continued)
    • Autologous serum skin test in action
    • How the autoimmune urticaria tests overlap
    • Testing for physical (inducible) urticarias
    • Confirming urticarial vasculitis
    • Working up angioedema without wheals
    • Algorithm for diagnosing angioedema
    • Algorithm for diagnosing chronic urticaria

    16 slides

  8. 08

    Treatment

    A stratified, three-line approach for urticaria, plus separate care for C1 inhibitor deficiency

    • The overall treatment strategy
    • Stepwise management of urticaria
    • First-line: H1 antihistamines
    • Antihistamines for urticaria
    • Antihistamines for urticaria (continued)
    • Classic vs second-generation antihistamines
    • Adding an H2 antagonist, and antihistamines in pregnancy
    • Second-line therapies: when to add them
    • Some second-line medications for chronic or physical urticaria
    • Corticosteroids and epinephrine: rescue, not routine
    • Doxepin and montelukast
    • Dapsone, sulfasalazine, and colchicine
    • Second-line options at a glance
    • Non-drug approaches
    • Third-line: omalizumab
    • Third-line: cyclosporine and other immunosuppressives
    • Treating C1 inhibitor deficiency: a different playbook
    • Preventing hereditary angioedema attacks

    18 slides

  9. 09

    Prognosis

    What patients can expect over time

    • Long-term outlook
    • Key takeaways

    2 slides

  10. 10

    References

    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    15 slides